Hints and tips:
Related Special Reports
...Alex Scott, executive vice-president for integrity at Eisai, said the data from Eli Lilly’s trial suggested donanemab “stops working” after 18 months....
...He has invested for years with his uncle, Dr Scott Freeman, a former pharmaceutical executive....
...It was Freeman’s uncle, Scott, who first introduced him to trading....
...The US pharmaceutical company said on Friday it was stopping the trial due to the “overwhelming efficacy”....
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
...Scott Gottlieb, a Pfizer director and former FDA commissioner, broadly confirmed the timeline given by D’Amelio....
...Scott Gottlieb, a former head of the FDA and a board member at Pfizer, defended the way the administration had handled the issue....
...“I think they’re having a very hard time modelling this and they don’t know where we are in this wave of infection,” Scott Gottlieb, former head of the Food and Drug Administration, told CNBC....
...“Africa is a key market for Sputnik V,” said the Russian Direct Investment Fund, a Kremlin-run wealth fund overseeing Sputnik V’s foreign sales....
...Scott Peters, the lead signatory on that letter, was the sixth-highest recipient in the House of money from the pharma industry in the last election cycle, according to the CRP....
...Australian Prime Minister Scott Morrison confirmed last week that his country pressured the UK to drop key climate commitments from its bilateral trade agreement....
...The news is “surprising to us; we expected Wichmann would be CEO for many years to come,” said Scott Fidel, analyst at Stephens, though he added that United does have “an extremely deep senior management...
...The idea was floated recently by Scott Gottlieb, the former head of the US Food and Drug Administration who now sits on the board of Pfizer....
...Scott Emerson, emeritus professor of biostatistics at the University of Washington, accused Biogen of cherry-picking data to prove the drug works, likening it to “someone first firing a shotgun at a barn...
...After such strong reads from the first two releases (three if we count Russia’s Sputnik V), the disappointing AZN figures were perhaps bound to prompt downward pressure on the company’s shares....
...In August, Russia became the first country to approve a Covid-19 vaccine — named Sputnik V — for civilian use, but western experts cast doubt on its efficacy and safety....
...If there is a sense from this earnings season that confidence in a V-shaped recovery for profits is misplaced, then the impact will probably be hardest on companies with weak balance sheets, and on those...
...Idexx said in October that the animal health market had experienced a “V-shaped recovery”....
...United’s incoming chief executive, Scott Kirby, said he would cut cash burn from $40m a day now towards $30m a day in the third quarter and then $20m a day in the fourth, if travel has not rebounded....
...Deutsche Bank’s satellite-powered shipping tracker indicates that Chinese economic activity has now stopped contracting, and some economists are predicting a V-shaped recovery....
...Their concentrated ownership of industries such as airlines and pharmaceuticals may push up travel and drug prices, some academics argue....
...Beyond these three biotechs, Crispr could end up transforming the entire pharmaceutical industry....
...Scott Gottlieb, the former chief of the US Food and Drug Administration, has joined Pfizer’s board of directors with immediate effect, the pharmaceutical company said on Thursday, in a move that could attract...
...Economists say a V-shaped recovery is unlikely. Even then it could be two Vs stuck together – a W, in other words....
...Virgin Louis V on my back, baby. Living fast, dying slow, that's the catch, baby. Suicide doors, [MUTED] around and crash, baby. I do the dash, baby....
International Edition